Stock Events

Stock Events

Tiziana Life Sciences 

€0.7950
43
-€0.04-5.36% Friday 19:46

Statistics

Day High
0.88
Day Low
0.76
52W High
1.26
52W Low
0.76
Volume
-
Avg. Volume
-
Mkt Cap
101.17M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18SepExpected
Q1 2026
Next
-0.08
-0.07
-0.07
-0.07
Expected EPS
-0.06963287956218
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RTRB.STU. It's not an investment recommendation.
Apple
10
AAPL
Tesla
10
TSLA
Microsoft
9
MSFT
Realty Income
8
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines for patients with serious diseases, including areas where Tiziana is active.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals is involved in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions, competing directly in the biotech space with Tiziana.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas overlapping with Tiziana's interests, particularly in oncology and inflammatory diseases.
AMGEN
AMGN
Mkt Cap196.12B
Amgen is a biotechnology pioneer that discovers, develops, manufactures, and delivers innovative human therapeutics, including treatments in areas that Tiziana Life Sciences targets.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on research and development in areas similar to Tiziana, such as immunology and oncology.
Merck
MRK
Mkt Cap305.12B
Merck & Co., Inc. is a global healthcare company that operates in the same therapeutic areas as Tiziana, making it a direct competitor in the pharmaceutical and biotech industry.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a global pharmaceutical corporation with a broad range of products in various therapeutic areas, including those being pursued by Tiziana, making it a competitor.
Novartis
NVS
Mkt Cap293.94B
Novartis is a global healthcare company that engages in the research, development, manufacturing, and marketing of a wide range of healthcare products, directly competing with Tiziana.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing in the same therapeutic areas as Tiziana.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in areas that overlap with Tiziana's focus.

About

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Show more...
CEO
Mr. Gabriele Marco Antonio Cerrone M.B.A.
Employees
10
Country
United Kingdom
ISIN
BMG889121031

Listings

STU
DE
0RP.STU
F
DE
0RP.F
STU
DE
RTRB.STU
MU
DE
0RP.MU

0 Comments

Share your thoughts

FAQ

What is Tiziana Life Sciences stock price today?▼
The current price of RTRB.STU is €0.80 EUR — it has decreased by -5.36% in the past 24 hours. Watch Tiziana Life Sciences stock price performance more closely on the chart.
What is Tiziana Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Tiziana Life Sciences stocks are traded under the ticker RTRB.STU.
What is Tiziana Life Sciences market cap?▼
Today Tiziana Life Sciences has the market capitalization of 101.17M
When is the next Tiziana Life Sciences earnings date?▼
Tiziana Life Sciences is going to release the next earnings report on September 18, 2026.
How many employees does Tiziana Life Sciences have?▼
As of July 26, 2026, the company has 10 employees.
In which sector is Tiziana Life Sciences located?▼
Tiziana Life Sciences operates in the Health & Wellness sector.
When did Tiziana Life Sciences complete a stock split?▼
Tiziana Life Sciences has not had any recent stock splits.
Where is Tiziana Life Sciences headquartered?▼
Tiziana Life Sciences is headquartered in London, United Kingdom.